Leucocyte depleting filter device and method of use

• US 5,362,406 A
• Filed: 03/09/1994
• Issued: 11/08/1994
• Est. Priority Date: 07/27/1990
• Status: Expired due to Term

• Current Assignee: Pall Corporation (Danaher Corporation)
• Original Assignee: Pall Corporation (Danaher Corporation)
• Inventors: Bormann, Thomas, Matkovich, Vlado I., Gsell, Thomas C.
• Primary Examiner(s): KIM, SUN U
• Application Number:
  US08/221,983
• Time in Patent Office: 244 Days
• Field of Search: 210/691, 210/750, 210/767, 210/788, 210/805, 210/188, 210/436, 210/422, 210/446, 210/472, 210/489, 210/492, 210/496, 210/497.01, 210/502.1, 210/504, 210/508 , 210/512.1, 210/503, 96/155, 96/176, 96/179, 96/189, 96/190, 96/191, 96/242, 604/4, 604/5, 604/122, 604/126
• US Class Current: 210/767
• CPC Class Codes: A61M 1/3633 Blood component filters, e.g. leukocyte filters
• CPC Class Codes: A61M 2202/0057 retained by adsorption
• CPC Class Codes: A61M 2202/0439 White blood cells; Leucocytes lymphocytes A61M2202/0407
• CPC Class Codes: A61M 2205/7536 allowing gas passage, but preventing liquid passage, e.g. liquophobic, hydrophobic, water-repellent membranes
• CPC Class Codes: A61M 2206/16 Rotating swirling helical flow, e.g. by tangential inflows
• CPC Class Codes: B01D 39/1623 of synthetic origin

Abstract

Leucocyte depletion filter assemblies and methods for removing leucocytes and other deleterious matter from a leucocyte-containing liquid are disclosed. Leucocyte depletion filter assemblies have a generally cylindrical housing having first and second chambers and an inlet into the first chamber and an outlet from the second chamber and a vent. A porous degassing element is positioned between the first and second chambers to remove gas from the liquid and the degassing element communicates with a vent covered with a liquophobic membrane which allows gas but not the liquid to flow through the vent. A hollow, cylindrical filter element is positioned in the second chamber and comprises a fibrous mass of microfibers capable of decreasing the leucocyte content of the liquid at a flow rate capacity of six liters per minute at a differential pressure of less than 15 psi. The mass of microfibers have a CWST of at least 53 dynes/cm and a graded pore size over at least a substantial radial portion of the microfibrous mass. The interior of the hollow filter element communicates with the outlet. These filter assemblies are suitable for use in an extracorporeal circuit. Leucocytes and other deleterious matter are removed from the leucocyte-containing liquid by passing the leucocyte-containing liquid through these filter assemblies.

Claims

1. A leucocyte depletion filter assembly for removing leucocytes and other deleterious matter from a leucocyte-containing liquid, the filter assembly comprising:

a generally cylindrical housing having first and second chambers, an inlet which allows tangential inflow into the first chamber, an outlet which allows outflow from the second chamber, and a vent;

a porous degassing element positioned between the first and second chambers to remove gas from the liquid;

a liquophobic membrane covering the vent and communicating with the degassing element to allow gas but not the liquid to flow through the vent; and

a hollow, cylindrical filter element positioned in the second chamber and comprising a fibrous mass of microfibers capable of decreasing the leucocyte content of the liquid at a flow rate capacity of six liters per minute at a differential pressure of less than 15 psi, said mass of microfibers having a CWST of at least 53 dynes/cm and a graded pore size over at least a substantial radial portion of the microfibrous mass, the interior of the hollow filter element communicating with the outlet.

2. The filter assembly of claim 1 wherein the filter element includes a total fibrous surface area of greater than about two square meters.

3. The filter assembly of claim 1 wherein the fibrous mass includes an upstream portion and a downstream portion, the upstream portion comprising generally coarser fibers than the downstream portion.

4. The filter assembly of claim 1 including a hold up volume in the range of from about 70 cc to about 400 cc.

5. The filter assembly of claim 4 including a hold up volume in the range of from about 180 cc to about 250 cc.

6. A method for removing leucocytes and other deleterious matter from a leucocyte-containing liquid comprising:

directing the liquid through a housing;

passing the liquid through a porous degassing element disposed within the housing;

venting gas from the housing through a vent in communication with the degassing element, wherein the vent includes a liquophobic membrane which allows the gas but not the liquid to flow through the vent; and

passing the liquid through a hollow, cylindrical filter element positioned within the housing, the filter element comprising a fibrous mass capable of decreasing the leucocyte content of the liquid at a flow rate capacity of six liters per minute at a differential pressure of less than 15 psi, said fibrous mass having a CWST of at least 53 dynes/cm and a graded pore size over at least a substantial radial portion of the fibrous mass.

7. The method of claim 6 wherein passing the leucocyte-containing liquid through the filter element includes passing blood through the element.

8. The method of claim 6 wherein directing the leucocyte-containing liquid through the housing comprises repeatedly circulating blood through the housing.

10. The method of claim 6 wherein passing the leucocyte-containing liquid through the filter element comprises decreasing the leucocyte content of the liquid by a clinically or therapeutically significant amount.

11. The method of claim 6 comprising passing the leucocyte-containing liquid through the filter element having a total fibrous surface area of greater than about two square meters.

9. The method of claim 41 wherein passing the leucocyte-containing liquid through the filter element comprises passing the liquid through a fibrous depth filter.